NeurAxis, Inc., a medical technology company specializing in neuromodulation therapies, is set to participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025. The company will deliver a webcast presentation at 9:30 a.m. ET and engage in virtual one-on-one meetings with investors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.